Personal tools

Coexpression cluster:C168

From FANTOM5_SSTAR

Revision as of 17:33, 8 August 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C168_Mast_CD14_immature_Basophils_Eosinophils_CD34_Peripheral



Phase1 CAGE Peaks

Hg19::chr10:126847337..126847340,+p@chr10:126847337..126847340
+
Hg19::chr10:127751126..127751139,-p@chr10:127751126..127751139
-
Hg19::chr10:17270214..17270247,+p5@VIM
Hg19::chr10:17270313..17270321,+p17@VIM
Hg19::chr10:17278167..17278185,+p12@VIM
Hg19::chr10:3846319..3846333,+p@chr10:3846319..3846333
+
Hg19::chr10:63805867..63805883,-p@chr10:63805867..63805883
-
Hg19::chr11:72470335..72470363,+p@chr11:72470335..72470363
+
Hg19::chr11:72470426..72470435,+p@chr11:72470426..72470435
+
Hg19::chr11:75051987..75052000,+p@chr11:75051987..75052000
+
Hg19::chr12:51787972..51787981,-p@chr12:51787972..51787981
-
Hg19::chr12:52432402..52432424,-p@chr12:52432402..52432424
-
Hg19::chr12:52444929..52444945,-p@chr12:52444929..52444945
-
Hg19::chr14:102553761..102553785,+p@chr14:102553761..102553785
+
Hg19::chr14:105143676..105143707,+p@chr14:105143676..105143707
+
Hg19::chr16:2560210..2560219,+p@chr16:2560210..2560219
+
Hg19::chr16:29302386..29302409,-p@chr16:29302386..29302409
-
Hg19::chr16:87887433..87887438,+p@chr16:87887433..87887438
+
Hg19::chr16:87887504..87887535,-p@chr16:87887504..87887535
-
Hg19::chr17:38476709..38476744,+p@chr17:38476709..38476744
+
Hg19::chr17:40168540..40168552,+p16@NKIRAS2
Hg19::chr17:41437738..41437747,-p3@AK023939
Hg19::chr17:41437922..41437939,+p@chr17:41437922..41437939
+
Hg19::chr17:72270457..72270470,+p3@DNAI2
Hg19::chr17:80250634..80250653,-p1@ENST00000499745
p1@uc002kek.1
Hg19::chr18:2848716..2848718,+p@chr18:2848716..2848718
+
Hg19::chr18:74206012..74206020,+p@chr18:74206012..74206020
+
Hg19::chr19:10527253..10527264,-p@chr19:10527253..10527264
-
Hg19::chr19:10542701..10542730,-p@chr19:10542701..10542730
-
Hg19::chr19:12902103..12902116,-p@chr19:12902103..12902116
-
Hg19::chr19:13951943..13951963,-p@chr19:13951943..13951963
-
Hg19::chr19:2168550..2168572,+p@chr19:2168550..2168572
+
Hg19::chr19:2476825..2476847,+p12@GADD45B
Hg19::chr19:2477163..2477216,+p2@GADD45B
Hg19::chr19:2477661..2477696,+p5@GADD45B
Hg19::chr19:2495478..2495481,-p@chr19:2495478..2495481
-
Hg19::chr19:2546698..2546709,-p@chr19:2546698..2546709
-
Hg19::chr19:2546728..2546743,-p@chr19:2546728..2546743
-
Hg19::chr19:2547016..2547029,+p@chr19:2547016..2547029
+
Hg19::chr19:45947743..45947780,+p@chr19:45947743..45947780
+
Hg19::chr19:45959758..45959769,+p@chr19:45959758..45959769
+
Hg19::chr19:49377218..49377242,+p@chr19:49377218..49377242
+
Hg19::chr19:49377471..49377488,+p@chr19:49377471..49377488
+
Hg19::chr19:49378119..49378134,+p@chr19:49378119..49378134
+
Hg19::chr19:49379626..49379630,-p@chr19:49379626..49379630
-
Hg19::chr19:54692317..54692331,+p@chr19:54692317..54692331
+
Hg19::chr1:1136756..1136767,-p@chr1:1136756..1136767
-
Hg19::chr1:1136782..1136795,-p@chr1:1136782..1136795
-
Hg19::chr1:161469716..161469730,+p@chr1:161469716..161469730
+
Hg19::chr1:168148677..168148693,+p@chr1:168148677..168148693
+
Hg19::chr1:224522323..224522330,+p@chr1:224522323..224522330
+
Hg19::chr1:226850887..226850894,+p@chr1:226850887..226850894
+
Hg19::chr1:235111193..235111206,+p@chr1:235111193..235111206
+
Hg19::chr22:22171149..22171186,+p@chr22:22171149..22171186
+
Hg19::chr22:44423030..44423043,+p@chr22:44423030..44423043
+
Hg19::chr22:50364701..50364715,+p@chr22:50364701..50364715
+
Hg19::chr2:145271497..145271510,+p@chr2:145271497..145271510
+
Hg19::chr2:157190984..157191018,-p@chr2:157190984..157191018
-
Hg19::chr2:157191084..157191095,-p@chr2:157191084..157191095
-
Hg19::chr2:157191294..157191331,+p@chr2:157191294..157191331
+
Hg19::chr2:157199008..157199023,-p3@NR4A2
Hg19::chr2:208394431..208394446,+p9@CREB1
Hg19::chr2:218767650..218767673,+p@chr2:218767650..218767673
+
Hg19::chr2:232476619..232476634,-p@chr2:232476619..232476634
-
Hg19::chr2:28114069..28114081,-p3@LOC100302650
Hg19::chr3:15837528..15837578,-p@chr3:15837528..15837578
-
Hg19::chr3:15839395..15839435,-p2@ANKRD28
Hg19::chr3:20227970..20227982,+p@chr3:20227970..20227982
+
Hg19::chr3:5020551..5020568,-p@chr3:5020551..5020568
-
Hg19::chr3:5048638..5048647,+p@chr3:5048638..5048647
+
Hg19::chr3:71150221..71150222,-p@chr3:71150221..71150222
-
Hg19::chr3:72532128..72532133,-p@chr3:72532128..72532133
-
Hg19::chr4:170581182..170581201,-p@chr4:170581182..170581201
-
Hg19::chr4:48533348..48533351,+p@chr4:48533348..48533351
+
Hg19::chr5:172185174..172185217,-p@chr5:172185174..172185217
-
Hg19::chr5:179245946..179245962,-p@chr5:179245946..179245962
-
Hg19::chr5:179245976..179245995,-p@chr5:179245976..179245995
-
Hg19::chr5:95297924..95297956,+p@chr5:95297924..95297956
+
Hg19::chr5:96038250..96038274,-p@chr5:96038250..96038274
-
Hg19::chr6:130005395..130005398,+p@chr6:130005395..130005398
+
Hg19::chr6:134610234..134610241,+p@chr6:134610234..134610241
+
Hg19::chr6:134617297..134617322,+p@chr6:134617297..134617322
+
Hg19::chr6:138187511..138187525,+p@chr6:138187511..138187525
+
Hg19::chr6:138200216..138200227,+p@chr6:138200216..138200227
+
Hg19::chr6:14711644..14711656,+p@chr6:14711644..14711656
+
Hg19::chr6:14712257..14712276,-p@chr6:14712257..14712276
-
Hg19::chr6:14712846..14712851,+p@chr6:14712846..14712851
+
Hg19::chr7:37726701..37726704,-p@chr7:37726701..37726704
-
Hg19::chr7:38409431..38409457,-p@chr7:38409431..38409457
-
Hg19::chr7:643862..643881,-p@chr7:643862..643881
-
Hg19::chr7:963120..963124,-p14@ADAP1
Hg19::chr8:103819280..103819302,+p2@ENST00000405813
p2@ENST00000517910
p2@uc003ykw.1
Hg19::chr8:12624204..12624207,-p@chr8:12624204..12624207
-
Hg19::chr8:2075387..2075430,-p@chr8:2075387..2075430
-
Hg19::chr8:29260411..29260429,+p@chr8:29260411..29260429
+
Hg19::chr8:38627853..38627874,-p@chr8:38627853..38627874
-
Hg19::chr8:81397624..81397636,-p@chr8:81397624..81397636
-
Hg19::chr9:102581773..102581785,-p@chr9:102581773..102581785
-
Hg19::chr9:107814448..107814480,+p@chr9:107814448..107814480
+
Hg19::chr9:108061944..108061969,+p@chr9:108061944..108061969
+
Hg19::chr9:127048403..127048433,+p9@NEK6
Hg19::chr9:132245474..132245496,-p@chr9:132245474..132245496
-
Hg19::chr9:33165989..33166005,+p@chr9:33165989..33166005
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0007243protein kinase cascade0.0148895998999346
GO:0007249I-kappaB kinase/NF-kappaB cascade0.0346361068868663
GO:0042069regulation of catecholamine metabolic process0.0346361068868663
GO:0035085cilium axoneme0.0346361068868663
GO:0042053regulation of dopamine metabolic process0.0346361068868663
GO:0042384cilium biogenesis0.0346361068868663
GO:0000185activation of MAPKKK activity0.0346361068868663
GO:0044441cilium part0.0424204890790849
GO:0048468cell development0.0427417232591816
GO:0030071regulation of mitotic metaphase/anaphase transition0.0427417232591816
GO:0042417dopamine metabolic process0.0427417232591816
GO:0000186activation of MAPKK activity0.0427417232591816
GO:0007091mitotic metaphase/anaphase transition0.0427417232591816
GO:0007165signal transduction0.0427417232591816
GO:0005858axonemal dynein complex0.0427417232591816
GO:0045103intermediate filament-based process0.0427417232591816
GO:0044447axoneme part0.0427417232591816
GO:0007154cell communication0.048522230700641
GO:0005930axoneme0.0489452501682876
GO:0032502developmental process0.0489452501682876



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
leukocyte1.05e-35140
myeloid leukocyte3.81e-2976
hematopoietic stem cell2.38e-28172
angioblastic mesenchymal cell2.38e-28172
hematopoietic lineage restricted progenitor cell3.91e-28124
CD14-positive, CD16-negative classical monocyte5.72e-2742
hematopoietic cell3.27e-26182
granulocyte monocyte progenitor cell5.68e-2671
classical monocyte6.11e-2645
hematopoietic oligopotent progenitor cell1.70e-25165
hematopoietic multipotent progenitor cell1.70e-25165
nongranular leukocyte2.41e-25119
myeloid lineage restricted progenitor cell1.68e-2470
macrophage dendritic cell progenitor1.24e-2265
monopoietic cell1.71e-2163
monocyte1.71e-2163
monoblast1.71e-2163
promonocyte1.71e-2163
myeloid cell5.47e-21112
common myeloid progenitor5.47e-21112
connective tissue cell7.54e-16365
mesenchymal cell1.30e-15358
motile cell2.87e-11390
Uber Anatomy
Ontology termp-valuen
hematopoietic system6.03e-30102
blood island6.03e-30102
hemolymphoid system2.84e-25112
bone marrow2.12e-2480
bone element2.63e-2386
skeletal element1.05e-17101
skeletal system1.05e-17101
immune system4.70e-17115
connective tissue3.31e-15375
blood5.63e-0715
haemolymphatic fluid5.63e-0715
organism substance5.63e-0715
lateral plate mesoderm6.32e-07216


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.